P043 Amphotericin B in pediatrics: analysis by age stratification suggests a greater chance of adverse events from 13-month of age onward

 : Poster session 1, September 21, 2022, 12:30 PM - 1:30 PM BACKGROUND: Deoxycholate amphotericin B (D-AMB) remains an antifungal of great therapeutic value in pediatrics. It is generally accepted that its use in neonates is safer than in older children. However, childhood presents different periods...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavassin, Francelise Bridi, Baú-Carneiro, João Luiz, de Araújo Motta, Fabio, Ville, Ana Paula Matzenbacher, Staszczak, Leticia, de Queiroz-Telles, Flavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510024/
http://dx.doi.org/10.1093/mmy/myac072.P043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510024/
http://dx.doi.org/10.1093/mmy/myac072.P043

Ejemplares similares